Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
38 hedge funds and large institutions have $87M invested in Axcella Health Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 3 closing their positions.
35,500% more call options, than puts
Call options by funds: $356K | Put options by funds: $1K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
73% more capital invested
Capital invested by funds: $50.4M → $87M (+$36.6M)
9% more funds holding
Funds holding: 35 → 38 (+3)
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$12.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$3.92M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$3.14M |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$160K |
| 5 |
Edgewood Management
Greenwich,
Connecticut
|
+$49.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$305K |
| 2 |
VF
Virtu Financial
New York
|
-$47K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$32.6K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$21K |
| 5 |
LC
Lindbrook Capital
Calabasas,
California
|
-$17K |
AXLA Hedge Fund Activity: Q1 2022 in Review
38 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q1 2022, worth a combined $87M — up 73% from $50.4M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new AXLA positions and 3 closed out — a net gain of 3 holders — while 11 added to existing stakes and 12 trimmed.
The largest buyer was Flagship Pioneering, adding an estimated $12.6M. The largest seller was Vanguard Group, cutting an estimated $305K.
- 38 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q1 2022, up from 35 in Q4 2021.
- Funds reported $87M of Axcella Health Inc. Common Stock stock for Q1 2022, up 73% quarter-over-quarter.
- 6 funds opened new Axcella Health Inc. Common Stock positions in Q1 2022 and 3 closed out, a net change of +3 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q1 2022 was Flagship Pioneering, an estimated $12.6M added.
- The largest Axcella Health Inc. Common Stock seller in Q1 2022 was Vanguard Group, an estimated $305K sold.
Based on aggregated 13F filings for Q1 2022.